Interprofessional Collaboration Between a Clinical Pharmacist and Specialty Physicians to Treat Hepatitis C in an Interdisciplinary Medical Practice Setting.

IF 1.1 Q4 PHARMACOLOGY & PHARMACY
Journal of Pharmacy Technology Pub Date : 2022-12-01 Epub Date: 2022-10-03 DOI:10.1177/87551225221125428
Jennifer T Fix, Steven Hauf, Michael Herrera, Randy Martin, Mason Sweeden, Karl Meyer
{"title":"Interprofessional Collaboration Between a Clinical Pharmacist and Specialty Physicians to Treat Hepatitis C in an Interdisciplinary Medical Practice Setting.","authors":"Jennifer T Fix,&nbsp;Steven Hauf,&nbsp;Michael Herrera,&nbsp;Randy Martin,&nbsp;Mason Sweeden,&nbsp;Karl Meyer","doi":"10.1177/87551225221125428","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> Describes the activities of a clinical pharmacist in a gastroenterology (GI) clinic providing services to hepatitis C virus (HCV) patients, with a focus on practice management activities and tools. <b>Practice Description:</b> Located inside a GI specialty clinic in Fort Worth, Texas, the pharmacist provides comprehensive medication management under a collaborative practice agreement (CPA). Once referred by the GI physician, the pharmacist has face-to-face patient visits, develops the care plan, orders medications, and follows patients through sustained virologic response and the development of a hepatocellular carcinoma surveillance plan. <b>Practice Innovation:</b> The role of pharmacists in the management of HCV is important to understand. This article details a pharmacist-led clinic in an open GI medical practice. <b>Evaluation:</b> A retrospective chart review study was conducted to assess outcomes related to the integration of the clinical pharmacist. <b>Methods:</b> Completed by the study team, this study included manual chart reviews of patients with the ambulatory care pharmacist-driven HCV practice to pull data and information that were then tabulated using Qualtrics. <b>Results:</b> A total of 95 charts were surveyed, 78 records were created, and 49 patients were started on direct-acting antiviral (DAA) treatment by the pharmacist. Patients required multiple pharmacist communication actions. The minimum duration of the pharmacist service was 6 months and could extend more than 9 months depending on the time it took to get the patient started on medication. Pharmacist integration into the practice resulted in improved intake for the GI clinic, improved interprofessional interaction, and increased utilization of newer treatment modalities for HCV which feature cure rates up to 99% with limited side effects. <b>Conclusion:</b> Clinical pharmacists are well positioned to help navigate patients through the complexities of the medication use system, medication access, drug interactions and adverse effects, promote medication adherence, and allow patients to start and complete therapy.</p>","PeriodicalId":16796,"journal":{"name":"Journal of Pharmacy Technology","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608105/pdf/10.1177_87551225221125428.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/87551225221125428","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/10/3 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Describes the activities of a clinical pharmacist in a gastroenterology (GI) clinic providing services to hepatitis C virus (HCV) patients, with a focus on practice management activities and tools. Practice Description: Located inside a GI specialty clinic in Fort Worth, Texas, the pharmacist provides comprehensive medication management under a collaborative practice agreement (CPA). Once referred by the GI physician, the pharmacist has face-to-face patient visits, develops the care plan, orders medications, and follows patients through sustained virologic response and the development of a hepatocellular carcinoma surveillance plan. Practice Innovation: The role of pharmacists in the management of HCV is important to understand. This article details a pharmacist-led clinic in an open GI medical practice. Evaluation: A retrospective chart review study was conducted to assess outcomes related to the integration of the clinical pharmacist. Methods: Completed by the study team, this study included manual chart reviews of patients with the ambulatory care pharmacist-driven HCV practice to pull data and information that were then tabulated using Qualtrics. Results: A total of 95 charts were surveyed, 78 records were created, and 49 patients were started on direct-acting antiviral (DAA) treatment by the pharmacist. Patients required multiple pharmacist communication actions. The minimum duration of the pharmacist service was 6 months and could extend more than 9 months depending on the time it took to get the patient started on medication. Pharmacist integration into the practice resulted in improved intake for the GI clinic, improved interprofessional interaction, and increased utilization of newer treatment modalities for HCV which feature cure rates up to 99% with limited side effects. Conclusion: Clinical pharmacists are well positioned to help navigate patients through the complexities of the medication use system, medication access, drug interactions and adverse effects, promote medication adherence, and allow patients to start and complete therapy.

临床药剂师和专业医师在跨学科医疗实践环境中治疗丙型肝炎的跨专业合作。
目的:介绍胃肠病(GI)诊所临床药剂师为丙型肝炎(HCV)患者提供服务的活动,重点介绍实践管理活动和工具。执业描述:药剂师位于德克萨斯州沃斯堡的一家胃肠道专科诊所内,根据合作执业协议(CPA)提供全面的药物管理。一旦得到胃肠道医生的转诊,药剂师就可以面对面拜访患者,制定护理计划,订购药物,并通过持续的病毒学反应和肝细胞癌监测计划的制定跟踪患者。实践创新:了解药剂师在丙型肝炎病毒管理中的作用很重要。这篇文章详细介绍了药剂师领导的开放胃肠道医疗实践诊所。评估:进行了一项回顾性图表审查研究,以评估与临床药剂师整合相关的结果。方法:本研究由研究团队完成,包括对门诊护理药剂师驱动的丙型肝炎患者进行手动图表审查,以提取数据和信息,然后使用Qualtrics将其制成表格。结果:共调查了95张图表,创建了78份记录,49名患者开始接受药剂师的直接作用抗病毒(DAA)治疗。患者需要多个药剂师沟通行动。药剂师服务的最短持续时间为6个月,根据患者开始服药的时间,可能会延长9个月以上。药剂师融入实践,提高了胃肠道诊所的摄入量,改善了跨专业的互动,并增加了对丙型肝炎新治疗模式的利用,其治愈率高达99%,副作用有限。结论:临床药剂师能够帮助患者了解药物使用系统、药物获取、药物相互作用和不良反应的复杂性,促进药物依从性,并让患者开始和完成治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pharmacy Technology
Journal of Pharmacy Technology PHARMACOLOGY & PHARMACY-
CiteScore
1.50
自引率
0.00%
发文量
49
期刊介绍: For both pharmacists and technicians, jPT provides valuable information for those interested in the entire body of pharmacy practice. jPT covers new drugs, products, and equipment; therapeutic trends; organizational, legal, and educational activities; drug distribution and administration; and includes continuing education articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信